04/02/2026
Stopping GLP-1 medications erodes heart health benefits faster than expected.
A new study followed more than 333,000 veterans with type 2 diabetes for three years. Patients who took GLP-1s continuously had an 18% reduction in cardiovascular risk.
But stopping for six months raised risk by 4%. Stopping for a year raised it to 14%.
Dr. Brad Serwer, VitalSolution's Chief Medical Officer, told Fox News: "When a crucial component of the therapeutic plan, such as medications like GLP-1, is discontinued, the disease process tends to resume at a rapid pace."
The study suggests GLP-1 drugs work best as long-term treatments combined with lifestyle changes.
Read more: https://www.foxnews.com/health/stopping-glp-1-drugs-like-ozempic-erodes-heart-health-benefits-quickly-new-study-finds